全文获取类型
收费全文 | 1740篇 |
免费 | 158篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 20篇 |
儿科学 | 75篇 |
妇产科学 | 28篇 |
基础医学 | 305篇 |
口腔科学 | 35篇 |
临床医学 | 136篇 |
内科学 | 363篇 |
皮肤病学 | 5篇 |
神经病学 | 113篇 |
特种医学 | 43篇 |
外科学 | 292篇 |
综合类 | 17篇 |
预防医学 | 116篇 |
眼科学 | 24篇 |
药学 | 71篇 |
肿瘤学 | 256篇 |
出版年
2021年 | 9篇 |
2020年 | 22篇 |
2019年 | 18篇 |
2018年 | 27篇 |
2017年 | 22篇 |
2016年 | 41篇 |
2015年 | 22篇 |
2014年 | 33篇 |
2013年 | 56篇 |
2012年 | 59篇 |
2011年 | 79篇 |
2010年 | 47篇 |
2009年 | 39篇 |
2008年 | 64篇 |
2007年 | 59篇 |
2006年 | 86篇 |
2005年 | 84篇 |
2004年 | 74篇 |
2003年 | 41篇 |
2002年 | 72篇 |
2001年 | 75篇 |
2000年 | 52篇 |
1999年 | 48篇 |
1998年 | 41篇 |
1997年 | 22篇 |
1996年 | 27篇 |
1995年 | 30篇 |
1994年 | 18篇 |
1993年 | 15篇 |
1992年 | 57篇 |
1991年 | 46篇 |
1990年 | 37篇 |
1989年 | 40篇 |
1988年 | 37篇 |
1987年 | 30篇 |
1986年 | 46篇 |
1985年 | 47篇 |
1984年 | 41篇 |
1983年 | 28篇 |
1982年 | 18篇 |
1980年 | 12篇 |
1979年 | 22篇 |
1978年 | 13篇 |
1977年 | 16篇 |
1975年 | 14篇 |
1974年 | 14篇 |
1973年 | 12篇 |
1972年 | 13篇 |
1971年 | 11篇 |
1968年 | 9篇 |
排序方式: 共有1899条查询结果,搜索用时 15 毫秒
51.
52.
53.
54.
Gardner LI Metsch LR Anderson-Mahoney P Loughlin AM del Rio C Strathdee S Sansom SL Siegal HA Greenberg AE Holmberg SD;Antiretroviral Treatment Access Study Study Group 《AIDS (London, England)》2005,19(4):423-431
OBJECTIVE: The Antiretroviral Treatment Access Study (ARTAS) assessed a case management intervention to improve linkage to care for persons recently receiving an HIV diagnosis. METHODS: Participants were recently diagnosed HIV-infected persons in Atlanta, Baltimore, Los Angeles and Miami. They were randomized to either standard of care (SOC) passive referral or case management (CM) for linkage to nearby HIV clinics. The SOC arm received information about HIV and local care resources; the CM intervention arm included up to five contacts with a case manager over a 90-day period. The outcome measure was self-reported attendance at an HIV care clinic at least twice over a 12-month period. RESULTS: A higher proportion of the 136 case-managed participants than the 137 SOC participants visited an HIV clinician at least once within 6 months [78 versus 60%; adjusted relative risk (RR(adj)), 1.36; P = 0.0005) and at least twice within 12 months (64 versus 49%; RR(adj), 1.41; P = 0.006). Individuals older than 40 years, Hispanic participants, individuals enrolled within 6 months of an HIV-seropositive test result and participants without recent crack cocaine use were all significantly more likely to have made two visits to an HIV care provider. We estimate the cost of such case management to be 600-1200 US dollars per client. CONCLUSION: A brief intervention by a case manager was associated with a significantly higher rate of successful linkage to HIV care. Brief case management is an affordable and effective resource that can be offered to HIV-infected clients soon after their HIV diagnosis. 相似文献
55.
Risk factors for syngeneic graft-versus-host disease after adult hematopoietic cell transplantation 总被引:1,自引:0,他引:1 下载免费PDF全文
Adams KM Holmberg LA Leisenring W Fefer A Guthrie KA Tylee TS McDonald GB Bensinger WI Nelson JL 《Blood》2004,104(6):1894-1897
Syngeneic graft-versus-host disease (sGVHD) has been described after hematopoietic cell transplantation (HCT) but remains poorly defined. We retrospectively reviewed adult syngeneic HCTs at our center (1980-2002) for sGVHD to investigate incidence, morbidity, and risk factors with a primary focus on parity. Among 119 transplantations, there were 21 cases of biopsy-proven sGVHD. The cumulative incidence was 18%, with multiorgan involvement in 6 cases and 1 death. sGVHD was more frequent when the donor was parous (32%) than nulliparous (9%) or male (13%; P = .03) and when the recipient was parous (31%) than nulliparous (7%) or male (13%; P = .02). Other univariable risk factors included older age (P < .01), busulfan/melphalan/thiotepa conditioning (P < .01), interleukin-2 (P = .02), HLA-A26 (P = .03), and more recent transplantation year (P < .01). Overall, risk factors were similar to those described in GVHD. Although an independent effect of parity could not be completely separated from other factors, donor and recipient pregnancy history merits further investigation. 相似文献
56.
Management of patients with community-acquired pneumonia treated in hospital in Sweden 总被引:1,自引:0,他引:1
Hedlund J Ortqvist A Ahlqvist T Augustinsson A Beckman H Blanck C Burman LA Claesson B Qvarfordt I Elbel E Erntell M Follin P Goscinski G Holmberg H Höfer M Jorup C Lidman C Lindhusen E Rensfeldt G Rosenkvist E Stenlund G Stålberg A Verngren K Vig I Wendahl S;Swedish Infectious Diseases Society Pneumonia Study Group 《Scandinavian journal of infectious diseases》2002,34(12):887-892
To investigate the management of patients with community-acquired pneumonia (CAP) treated in hospital in Sweden, a multicentre retrospective cohort study was performed with medical record review of 982 patients (mean age 63 y) at 17 departments of infectious diseases at hospitals in Sweden. Information on antimicrobial therapy, demographic characteristics, comorbid conditions, physical examination findings, and laboratory and microbiological test results were recorded. Outcome measures were in-hospital mortality and length of hospital stay (LOS). Cultures were obtained from blood in 80% and from sputum in 22% of the patients. A microbiological aetiology was determined for 23% of the patients, with Streptococcus pneumoniae as the dominating agent (9%). The initial antibiotic treatment was mostly given intravenously (78%). Penicillin (50%) or a cephalosporin (30%) was the most common choice. Both of these drugs were usually given as a single agent. The overall mortality was 3.5% and the mean LOS was 6.4 d. Thus, the outcome was favourable despite the empirical antibiotic treatment having a narrow spectrum compared with the broader approach recommended in most recent guidelines on the management of CAP. These findings suggest that a majority of patients who are hospitalized with moderately severe pneumonia can be treated initially with penicillin alone. 相似文献
57.
Victor A. Chow MD Joseph G. Rajendran MD Darrell R. Fisher Frederick R. Appelbaum MD Ryan D. Cassaday MD Paul S. Martin MD Leona A. Holmberg MD PhD Theodore A. Gooley PhD Philip A. Stevenson MS John M. Pagel MD PhD Damian J. Green MD Oliver W. Press MD PhD Ajay K. Gopal MD 《American journal of hematology》2020,95(7):775-783
Radiation is the most effective treatment for localized lymphoma, but treatment of multifocal disease is limited by toxicity. Radioimmunotherapy (RIT) delivers tumoricidal radiation to multifocal sites, further augmenting response by dose-escalation. This phase II trial evaluated high-dose RIT and chemotherapy prior to autologous stem-cell transplant (ASCT) for high-risk, relapsed or refractory (R/R) B-cell non-Hodgkin lymphoma (NHL). The primary endpoint was progression free survival (PFS). Secondary endpoints were overall survival (OS), toxicity, and tolerability. Patients age < 60 years with R/R NHL expressing CD20 were eligible. Mantle cell lymphoma (MCL) patients could proceed to transplant in first remission. Patients received I-131-tositumomab delivered at ≤25Gy to critical normal organs, followed by etoposide, cyclophosphamide and ASCT. A group of 107 patients were treated including aggressive lymphoma (N = 29), indolent lymphoma (N = 45), and MCL (N = 33). After a median follow-up of 10.1 years, the 10-year PFS for the aggressive, indolent, and MCL groups were 62%, 64%, 43% respectively. The 10-year OS for the aggressive, indolent, and MCL groups were 61%, 71%, 48% respectively. Toxicities were similar to standard conditioning regimens and non-relapse mortality at 100 days was 2.8%. Late myeloid malignancies were seen in 6% of patients. High-dose I-131-tositumomab, etoposide and cyclophosphamide followed by ASCT appeared feasible, safe, and effective in treating NHL, with estimated PFS at 10-years of 43%-64%. In light of novel cellular therapies for R/R NHL, high-dose RIT-containing regimens yield comparable efficacy and safety and could be prospectively compared. 相似文献
58.
59.
60.